BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 5011257)

  • 1. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L; Caldwell BV; Brock WA; Anderson GG; Hobbins JC
    J Clin Endocrinol Metab; 1972 Mar; 34(3):531-6. PubMed ID: 5011257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of infused prostaglandin F 2 on hormonal levels during early pregnancy.
    Wentz AC; Jones GS; Graeber J
    Am J Obstet Gynecol; 1972 Dec; 114(7):908-13. PubMed ID: 4645129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in peripheral hormone levels after therapeutic abortion.
    Saunders DM; Kelso IM; Grudzinskas JG; Hughes GJ; Wilson GR
    Eur J Obstet Gynecol Reprod Biol; 1978 Feb; 8(1):1-4. PubMed ID: 95666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum gonadotropin and steroid patterns in early human gestation.
    Mishell DR; Thorneycroft IH; Nagata Y; Murata T; Nakamura RM
    Am J Obstet Gynecol; 1973 Nov; 117(5):631-42. PubMed ID: 4742372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma hormone concentrations in induced abortion with local prostaglandin administration in the 1st trimester].
    Rath W; König A; Ulbrich R; Hilgers R; Kuske R; Kuhn W
    Zentralbl Gynakol; 1983; 105(15):961-71. PubMed ID: 6578640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional life span of the corpus luteum gravidarum: an estimation from the mode of fluctuation of serum hormones after artificial termination of pregnancy and succeeding exogenous hCG administration.
    Ando S
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1566-74. PubMed ID: 7130777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma hormone changes during infusions of prostaglandins F2alpha and E2 for therapeutic abortion.
    Newton J; Collins W
    Adv Biosci; 1973; 9():689-99. PubMed ID: 4805881
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the actions of the 15-methyl analogs of prostaglandins E2 and f-2 alpha on hormone levels after their administration for therapeutic abortion.
    Salmon JA; Ghodgonkar R; Telli AH
    Prostaglandins; 1974 Jan; 5(2):197-207. PubMed ID: 4816725
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandin E2 and the luteal phase of the menstrual cycle: effects on blood progesterone, estradiol, cortisol, and growth hormone levels.
    Henzl MR; Ortega E; Cortés-Gallegos V; Tomlinson RV; Segre EJ
    J Clin Endocrinol Metab; 1973 Apr; 36(4):784-7. PubMed ID: 4686386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midtrimester intra-aminotic administration of prostaglandin F2alpha in combination with an hyperosmolar urea solution: effect upon plasma levels of estradiol, progesterone, and human placental lactogen (HPL).
    Sher G; Katz M
    Acta Obstet Gynecol Scand; 1978; 57(3):223-5. PubMed ID: 665164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women.
    Arrata WS; Chatterton RT
    Am J Obstet Gynecol; 1974 Dec; 120(7):954-9. PubMed ID: 4429112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Scher J; Jeng DY; Kerenyi TD
    Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in estrogen levels in maternal venous plasma after intra-amniotic infusion of prostaglandin F2 for therapeutic abortion.
    Shutt DA; Smith ID; Shearman RP
    Prostaglandins; 1973 Aug; 4(2):291-9. PubMed ID: 4729615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous infusion of prostaglandin F2alpha in the mid-luteal phase of the normal human menstrual cycle.
    Jewelewicz R; Cantor B; Dyrenfurth I; Warren MP; Vande Wiele RL
    Prostaglandins; 1972 Jun; 1(6):443-51. PubMed ID: 4660079
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of prostaglandin f2alpha on endocrine parameters in early pregnancy.
    Schmidt-Gollwitzer M; Leyendecker G
    Arch Gynakol; 1977 Mar; 222(2):149-57. PubMed ID: 577127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolysis in humans and subhuman primates.
    Henzl MR
    Res Prostaglandins; 1972 May; 1(5):1-3. PubMed ID: 12337004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone changes in relation to the time of fetal death after prostaglandin-induced abortion.
    Fraser IS; Nicholson KM; Graham G; Boyle H
    Prostaglandins; 1977 Jun; 13(6):1161-7. PubMed ID: 887804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.